In a twist worthy of Hercule Poirot, ESPN reports Jarrell Miller has tested positive for the performance-enhancing substance GW1516 ahead of his June 1st bout with Anthony Joshua. The positive result came from a random VADA test on March 20th.
No word yet as to the fight’s status, though Joshua promoter Eddie Hearn chimed in.
We have been informed by VADA that there has been an adverse finding in Jarrell Miller’s sample collected on March 20th, 2019. We are working with all relevant parties and will update with more details soon. AJ’s preparation continues for June 1st at MSG.— Eddie Hearn (@EddieHearn) April 17, 2019
Any layman looking at Miller and Joshua’s respective builds would be flabbergasted by this news, but as any MMA fan can tell you, the eye test isn’t foolproof.
I don’t know jack about GW1516, so let’s head over to Wikipedia. Also known as Endurobol or Cardarine, the drug is a selective androgen receptor modulator (SARM) that has been around since the 1990s. SARMs have been prohibited by WADA since 2008; Ostarine, which Lucian Bute and Alexander Povetkin tested positive for, is another example.
With Katie Taylor vs. Delfine Persoon and several other prominent names attached, one would imagine that the show will go on regardless, most likely with Joshua facing someone else. We’ll keep you updated as the situation develops.